> it really does, in retrospect, look like a lot of it was trying to get people onto a yearly vaccine plan I think, yes, the companies are for sure rubbing th

> it really does, in retrospect, look like a lot of it was trying to get people onto a yearly vaccine plan I think, yes, the companies are for sure rubbing their hands and thinking about the extra money from another mandated yearly vaccine. But the SARS-CoV-2 vaccines, though they have a short window of effectiveness (as do flu vaccines) have protected some people from severity of the symptoms and death, which is not a bad thing. There may be some value in a yearly vaccine for at least susceptible people that covers a window of time where infection rates are typically highest.